January 20, 2014

The Food and Drug Administration recently approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (i.e., cannot be removed by surgery) or metastatic (i.e., late-stage), Onco360 announced last week.

October 17, 2012

A cancer drug made by Bristol-Myers Squibb has received an award from Galien Foundation, the drug maker said Wednesday.

June 2, 2011

Bristol-Myers Squibb will collaborate with Roche to investigate the use of a combination of the companies’ drugs in patients with a deadly form of skin cancer.

March 25, 2011

The Food and Drug Administration has approved a new treatment for late-stage skin cancer, the agency said Friday.

March 24, 2011

Bristol-Myers Squibb said its late-stage clinical trial for a cancer treatment, which currently is under review by the Food and Drug Administration, achieved its primary endpoint.

August 17, 2010

The Food and Drug Administration has agreed to expedite review of an investigational treatment for...

June 21, 2010

Cases of the potentially deadly skin cancer melanoma are expected to almost double before the...

June 6, 2010

An investigational drug for skin cancer that had spread to other parts of the body...

January 6, 2010

Two drug makers have entered an agreement to develop a drug designed to treat melanoma....